Riskpilot← Back to searchSign inGet full accessNymLiBor AB
ABActiveOrg 5592113525Huvudnäsgatan 34Business and other management consultancy activities · NACE 7020Est. 20190 employees
Revenue 2025
SEK 289K
+72246% vs 2024
EBITDA margin
69.6%
+2333% vs 2024
Equity ratio
52.0%
Financial strength
Net profit 2025
SEK 119K
+2353% vs 2024
| Revenue | SEK 289K | +72246% |
| EBITDA | SEK 201K | +2333% |
| Net profit | SEK 119K | +2353% |
| Total assets | SEK 350K | +176% |
| Equity | SEK 182K | +134% |
| Employees | 0 | — |
Legal name
NymLiBor AB
Org number
5592113525
Legal form
Aktiebolag
NACE code
7020 · Business and other management consultancy activities
Founded
3 juli 2019
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Medicinsk fotvård, med inköp och försäljning av fotvårdsartikar, skor, väskor, jackor Inköp och försäljning av heminredning, tyg Konsultverksamhet inom teknisk utrustning och rådgivning, främst med inriktning mot mätteknik Inköp och försäljning av motordelar, däck, bilutrusning, rallytillbehör
Address
Huvudnäsgatan 34
Email
lilian.nyman@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 149 | 187 | 42 | 0 | 289 |
| Staff expenses | — | −186 | −16 | −0 | −45 |
| EBITDA | 17 | 0 | 93 | 8 | 201 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 17 | 0 | 93 | 8 | 201 |
| Net financials | — | −0 | 0 | 0 | −0 |
| Profit before tax | 13 | 0 | 73 | 6 | 151 |
| Tax | −3 | −0 | −15 | −1 | −32 |
| Net profit | 10 | 0 | 58 | 5 | 119 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 90 | 93 | 172 | 127 | 350 |
| Equity | 65 | 65 | 123 | 77 | 182 |
| Long-term debt | 1 | 0 | — | — | 10 |
| Short-term debt | 18 | 22 | 24 | 21 | 80 |
| Total debt | 19 | 22 | 24 | 21 | 90 |
EBITDA margin
69.6%
This company
15.8%
Market median
+341% vs market
20212025
Equity ratio
52.0%
This company
38.2%
Market median
+36% vs market
20212025
Return on equity
65.6%
This company
18.4%
Market median
+257% vs market
20212025
Net profit margin
41.2%
This company
8.1%
Market median
+409% vs market
20212025
Asset turnover
0.83×
This company
1.12×
Market median
+26% vs market
20212025
Debt / equity
0.92×
This company
0.62×
Market median
+48% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-03-01 – 2025-02-28
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-03-01 – 2024-02-29
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-03-01 – 2023-02-28
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-03-01 – 2022-02-28
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-02-28
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NymLiBor AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Julia Agnes Henningberg | Deputy Board Member | 0 companies |
| Lilian Margareta Nyman | Chairman | 0 companies |
| Björn Karl-Erik Nyman | Board of Directors | 0 companies |